Lilly Weight-Loss Drug Copycat Makers Sue FDA Over Shortage End

A group representing companies that made copycat versions of Eli Lilly & Co.’s weight-loss drugs sued the US Food and Drug Administration over the agency’s decision to remove Lilly’s medications from its shortage list.

The Outsourcing Facilities Association, which represents bulk compounders, alleged that the FDA’s decision was arbitrary, capricious, and “contrary to law,” in its complaint, filed in federal court in Texas. The plaintiffs, including compounding pharmacy FarmaKeio Custom Compounding, said the FDA should have given advance notice of its decision and solicited public comments.

The plaintiffs alleged that the shortage of Lilly’s drugs isn’t actually over, ...